The World Health Organisation (WHO) has issued revised guidelines on rabies prophylaxis by incorporating a low-cost treatment protocol recommended by a Himachal Pradesh government doctor for dog-bite patients.
The Technical Report Series (1012) released on Friday, based on WHO's Expert Consultation, referenced two papers based on practical research by field epidemiologist Omesh Kumar Bharti on the dose and use of rabies immunoglobulins in such patients.
The 195-page report on rabies prevention recommends that apart from anti-rabies vaccination, insertion of rabies immunoglobulins in dog-bite wounds only is effective, a protocol established by Bharti.
"While intra-dermal vaccine's doses have been reduced to three from four in the latest guidelines (based on research in Cambodia and Tanzania), the WHO has recommended injection of rabies immunoglobulins now only in dog-bite wounds," Bharti, posted at the Intra Dermal Anti-Rabies Clinic and Research Centre of the Deen Dayal Upadhyay Hospital here, told IANS.
He said the treatment cost for a dog-bite patient will resultantly be roughly Rs 350 ($5.50) only from existing Rs 35,000 ($545).
As per the WHO's 2010 guidelines, now replaced by the 2018 guidelines, any dog- or monkey-bite patient was administered vaccine intradermally, along with injection of rabies immunoglobulins in wound(s) and also intramuscularly.
As per the earlier protocol, rabies immunoglobulins to be injected were calculated on the basis of body weight of a patient, which was a costly option.
The new WHO guidelines no longer recommend intramuscular administration of rabies immunoglobulins.
Bharti's undertook the research initiative in 2014 when he saw a few deaths due to scant availability of rabies immunoglobulins in the market in the hill state.
"The low-dose protocol, backed by existing literature, has helped increase availability of rabies immunoglobulins for dog-bite patients in hospitals," he said.
He said that he undertook the research with technical support from late S.N. Madhusudana, the then head of WHO Collaborative Rabies Research Centre at the National Institute of Mental Health and Neurosciences, Bengaluru, and Henry Wilde, a noted rabies researcher and WHO consultant in Thailand.
--IANS
vg/tsb/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
